Search for: "Winston v. State" Results 101 - 120 of 411
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jan 2018, 12:10 pm
Collins-McGregor and Winston were the appellees in this case and will be referred to hereinafter as the “Oil and Gas Companies”. [read post]
22 Jan 2018, 12:10 pm
Collins-McGregor and Winston were the appellees in this case and will be referred to hereinafter as the “Oil and Gas Companies”. [read post]
11 Dec 2017, 8:00 am by Dan Ernst
West Virginia State Board of Education: The Flag Salute Cases, by by Winston Bowman, Associate Historian, Federal Judicial History Office, Federal Judicial Center. [read post]
26 Oct 2017, 4:17 am by Andrew Lavoott Bluestone
  They were set forth in bullet fashion in the opinion: “The allegation that, while representing plaintiff in the assignment-of-lease negotiations, counsel secretly represented the counterparty so as to obtain favorable terms for the counterparty, which resulted in a lower-than-market price for the assignment, states a claim for legal malpractice (see Leggiadro, Ltd. v Winston & Strawn, LLP, 119 AD3d 442 [1st Dept 2014]). [read post]
20 Sep 2017, 12:58 pm by Woodruff Family Law Group
Woodruff, North Carolina Family Law Specialist Winston Salem, North Carolina: Malecek v. [read post]
20 Sep 2017, 12:58 pm by Woodruff Family Law Group
Woodruff, North Carolina Family Law Specialist Winston Salem, North Carolina: Malecek v. [read post]
21 Jul 2017, 6:04 am
Pastuszenski, Goodwin Procter LLP, on Tuesday, July 18, 2017 Tags: California, Class actions, Jurisdiction, New York, PSLRA, Securities Act, Securities litigation, Shareholder suits, SLUSA, State law, Supreme Court CalPERS v. [read post]
16 Jun 2017, 3:00 am by SOG Staff
Supreme Court apparently is considering whether to hear a case, Wisconsin v. [read post]
13 Mar 2017, 10:00 am by Thomas Dowdell (US)
Winston & Co., a member of the product investment board of GlaxoSmithKline, and a senior fellow at the American Enterprise Institute. [read post]
12 Mar 2017, 9:28 am
 On the 26 April 2017, the US Supreme Court will hear arguments on this issue in Sandoz v Amgen. [read post]